CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to TXMD

Brepocitinib PO QD

Phase 3
TherapeuticsMD, Inc. (TXMD)

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Sep '26
TXMDPhase 3
✓Completed

Brepocitinib PO QD Phase 3 Est. Readout

Brepocitinib PO QD
Sep 2026~
CT.gov
Competitive Landscape

0 competitors in Uveitis, Posterior

View Full Landscape
Drug Information

Target Indication

Uveitis, Posterior

Clinical Trial

NCT06431373

Last updated: 7/25/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.